TherapeuticsMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	1.76	1.3	69.96	2.57	64.87	Upgrade
Revenue Growth (YoY)	35.25%	-98.14%	2619.12%	-96.03%	30.67%	Upgrade
Cost of Revenue	-	-	1.4	1.4	15.98	Upgrade
Gross Profit	1.76	1.3	68.57	1.17	48.9	Upgrade
Selling, General & Admin	4.74	8.9	56.71	72.75	192.87	Upgrade
Research & Development	-	-	-	-	10.43	Upgrade
Operating Expenses	5.25	9.83	57.9	72.75	203.31	Upgrade
Operating Income	-3.49	-8.52	10.66	-71.58	-154.41	Upgrade
Interest Expense	-	-	-	-	-28.58	Upgrade
Other Non Operating Income (Expenses)	2.42	0.78	-0.12	0.27	0.6	Upgrade
EBT Excluding Unusual Items	-1.08	-7.74	10.55	-71.31	-182.39	Upgrade
Merger & Restructuring Charges	-	-	-9.47	-	-	Upgrade
Asset Writedown	-1.27	-	-	-	-1.13	Upgrade
Other Unusual Items	-	-	-	-8	-	Upgrade
Pretax Income	-2.34	-7.74	1.07	-79.31	-183.52	Upgrade
Income Tax Expense	-0.03	-0.04	-	-	-	Upgrade
Earnings From Continuing Operations	-2.31	-7.7	1.07	-79.31	-183.52	Upgrade
Earnings From Discontinued Operations	0.13	-2.58	110.92	-93.11	-	Upgrade
Net Income	-2.18	-10.28	112	-172.42	-183.52	Upgrade
Net Income to Common	-2.18	-10.28	112	-172.42	-183.52	Upgrade
Shares Outstanding (Basic)	12	10	9	8	6	Upgrade
Shares Outstanding (Diluted)	12	10	9	8	6	Upgrade
Shares Change (YoY)	10.45%	11.48%	17.66%	44.39%	11.89%	Upgrade
EPS (Basic)	-0.19	-0.98	12.41	-21.66	-33.29	Upgrade
EPS (Diluted)	-0.19	-0.99	11.95	-21.66	-33.50	Upgrade
Free Cash Flow	0.73	-48.14	-4.08	-142.73	-159.68	Upgrade
Free Cash Flow Per Share	0.06	-4.61	-0.43	-17.93	-28.96	Upgrade
Gross Margin	100.00%	100.00%	98.00%	45.51%	75.38%	Upgrade
Operating Margin	-198.30%	-654.61%	15.24%	-2781.85%	-238.02%	Upgrade
Profit Margin	-123.85%	-789.40%	160.08%	-6700.93%	-282.90%	Upgrade
Free Cash Flow Margin	41.57%	-3697.46%	-5.83%	-5547.10%	-246.14%	Upgrade
EBITDA	-2.98	-8.4	11.86	-70.84	-150.34	Upgrade
EBITDA Margin	-169.39%	-	16.95%	-	-231.75%	Upgrade
D&A For EBITDA	0.51	0.12	1.19	0.74	4.07	Upgrade
EBIT	-3.49	-8.52	10.66	-71.58	-154.41	Upgrade
EBIT Margin	-198.30%	-	15.24%	-	-238.02%	Upgrade
Revenue as Reported	-	1.3	69.96	2.57	64.87	Upgrade
Advertising Expenses	-	-	-	-	35.8	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q